Assaying Cell Cycle Progression via Flow Cytometry in CRISPR/Cas9-Treated Cells

Area of Science:

• Molecular Biology
• Cell Biology
• Genomics

Background:

• The CRISPR/Cas9 system is a revolutionary genome editing tool.
• Efficiently generating large populations of edited cells remains a challenge for certain cell types.
• CRISPR/Cas9-induced cell cycle arrest is a potential limiting factor for editing efficiency.

Purpose of the Study:

• To develop and validate a flow cytometry-based assay for assessing cell cycle progression following CRISPR/Cas9 treatment.
• To evaluate the impact of CRISPR/Cas9 on cell cycle dynamics in various cell lines.
• To provide a method for optimizing interventions to increase the yield of edited cells.

Main Methods:

• Development of a flow cytometry assay.
• Quantification of cell cycle profiles (e.g., G1, S, G2/M phases) after CRISPR/Cas9 treatment.
• Assessment of Cas9 vector transfection and expression efficiencies.

Main Results:

• The assay successfully determines cell cycle progression in the presence of CRISPR/Cas9.
• It allows for the evaluation of transfection and expression efficiencies of Cas9 vectors.
• The method facilitates the assessment of interventions aimed at improving the number of edited cells.

Conclusions:

• This flow cytometry assay is a valuable tool for understanding CRISPR/Cas9-mediated cell cycle effects.
• It aids researchers in troubleshooting and optimizing genome editing protocols.
• The assay supports the efficient generation of larger populations of CRISPR/Cas9-edited cells.